Company Quick10K Filing
SPYR
10-Q 2021-03-31 Filed 2021-05-17
S-1 2021-02-03 Public Filing
10-K 2020-12-31 Filed 2021-03-31
S-1 2020-11-13 Public Filing
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-14
S-1 2018-08-31 Public Filing
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-12-31 Filed 2018-08-14
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-24
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-30
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-03-31 Filed 2014-05-14
10-Q 2014-03-31 Filed 2014-08-14
10-K 2013-12-31 Filed 2014-04-15
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-14
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-03-31
8-K 2020-10-31
8-K 2020-10-20
8-K 2020-10-05
8-K 2020-04-14
8-K 2019-02-21
8-K 2018-08-01
8-K 2018-07-02
8-K 2018-07-02
8-K 2018-06-22
8-K 2018-06-18
8-K 2018-03-10
8-K 2018-02-19
8-K 2018-01-22

SPYR Financials

SPYR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1,0289017137376404503835085681,9451,6297,8267,4176,9947,2327,3097,2566,9045,8905,0143,8653,2042,2961,30328586781684224262336
Accounts Receivable1011120791655482822224448211243188362242435
Inventory111112121212131313131616201414141113101010128
PP&E8608603763793233113833843843842272093853854065285496006416486486486473512492492492492492472477667
Assets2,4341,7651,6061,6401,6581,2571,2201,7104,7876,59713,75322,88915,67713,27613,14012,14210,6237,7037,1746,5435,3273,8602,8091,9118231,0781,0131,069998342396375380
Accounts Payable
Long-Term Debt440
Liabilities5,6785,2185,0354,9764,9614,8622,5642,5852,4992,38410,48410,68312,019343145236283112139791831762223014961,7071,9773,8442,4573,0083,3813,8394,091
Stockholders' Equity-3,244-3,452-3,429-3,336-3,304-3,605-1,344-8752,2874,2133,26912,2063,65812,93312,99511,90610,3407,5917,0356,4635,1443,6842,5871,610327-629-964-2,775-1,459-2,666-2,985-3,464-3,711
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue164401342313290270246277334365338337362360432712466-1333237443141436432261862111677918
Cost of Revenue23124118909488104859713113010614113810110315511597951319799-80
Gross Profit141277224223195182143193241234208231221222332610311-128235279300317265196
R&D113152542464299154137179
SG&A2,2692,4461,149-3851,1611,2242,0833,3333,567
Tax004000000000-159-626000000000000000000
Net Income153-2003522178-1452,0903503,766932-5,9347,235-71-1,531-3,334-1,592-1,592-2,427-813-1,138-2,024-3,415-3,457-2,256-3,154-7,258-3,951-1,064-933-450-529-247
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-1251-11-37-20-2-31-243626-53-217-2,426-469-1,014-647-786-639-974-952-1,360-908-1,243-1,168-799-816-660-224-207-283-247
Cash Investing172-314107-9-40-651763741,490-3436,251-684037071,090595433-37183-1976990-50-50000-25000
Cash Financing-28875-72-50-1300-20-290-1500001,600000001500200600810750123209280260